196 related articles for article (PubMed ID: 34157632)
1. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
Bae H; Cho YW; Kim KT; Allen RP; Earley CJ
Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome.
Cho YW; Allen RP; Earley CJ
Sleep Med; 2018 Feb; 42():7-12. PubMed ID: 29458749
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome.
Cho YW; Allen RP; Earley CJ
Sleep Med; 2016 Sep; 25():16-23. PubMed ID: 27823710
[TBL] [Abstract][Full Text] [Related]
4. Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.
Bae H; Cho YW; Kim KT; Li X; Earley CJ
Sleep Med; 2023 Sep; 109():128-131. PubMed ID: 37437492
[TBL] [Abstract][Full Text] [Related]
5. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
Schneider J; Krafft A; Manconi M; Hübner A; Baumann C; Werth E; Gyr T; Bassetti C
Sleep Med; 2015 Nov; 16(11):1342-1347. PubMed ID: 26498233
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
[TBL] [Abstract][Full Text] [Related]
7. Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome.
Park HR; Choi SJ; Joo EY; Allen RP
Sleep Med; 2020 Nov; 75():81-87. PubMed ID: 32853922
[TBL] [Abstract][Full Text] [Related]
8. Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.
Trenkwalder C; Winkelmann J; Oertel W; Virgin G; Roubert B; Mezzacasa A;
Mov Disord; 2017 Oct; 32(10):1478-1482. PubMed ID: 28643901
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of intravenous iron for patients with restless legs syndrome: evidence from randomized trials and observational studies.
Yang X; Yang B; Ming M; Li S; Wang F; Zhu Z; Ji C; Long J; Hu F; Xu Z; Ren H; Liu B
Sleep Med; 2019 Sep; 61():110-117. PubMed ID: 31395522
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder.
DelRosso LM; Ferri R; Chen ML; Kapoor V; Allen RP; Mogavero MP; Picchietti DL
Sleep Med; 2021 Nov; 87():114-118. PubMed ID: 34562823
[TBL] [Abstract][Full Text] [Related]
11. Does Repeated Dosing of Intravenous Ferric Carboxymaltose Alleviate Symptoms of Restless Legs Syndrome?
Park HR; Choi SJ; Joo EY
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329998
[TBL] [Abstract][Full Text] [Related]
12. Clinical Efficacy and Safety of Intravenous Ferric Carboxymaltose for Treatment of Restless Legs Syndrome: A Multicenter, Randomized, Placebo-controlled Clinical Trial.
Earley CJ; García-Borreguero D; Falone M; Winkelman JW
Sleep; 2024 Apr; ():. PubMed ID: 38625730
[TBL] [Abstract][Full Text] [Related]
13. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
Hornyak M; Scholz H; Kiemen A; Kassubek J
Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006
[TBL] [Abstract][Full Text] [Related]
14. A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
Short V; Allen R; Earley CJ; Bahrain H; Rineer S; Kashi K; Gerb J; Auerbach M
Am J Hematol; 2024 Jun; 99(6):1077-1083. PubMed ID: 38476079
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment for restless legs symptoms and low serum ferritin in children with autism spectrum disorder.
DelRosso LM; Reuter-Yuill LM; Cho Y; Ferri R; Mogavero MP; Picchietti DL
Sleep Med; 2022 Dec; 100():488-493. PubMed ID: 36265207
[TBL] [Abstract][Full Text] [Related]
16. Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients.
Lieske B; Becker I; Schulz RJ; Polidori MC; Kassubek J; Roehrig G
Z Gerontol Geriatr; 2016 Oct; 49(7):626-631. PubMed ID: 26597718
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
Macher S; Herster C; Holter M; Moritz M; Matzhold EM; Stojakovic T; Pieber TR; Schlenke P; Drexler C; Amrein K
Nutrients; 2020 May; 12(5):. PubMed ID: 32380660
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
Geisser P; Banké-Bochita J
Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
[TBL] [Abstract][Full Text] [Related]
19. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
[TBL] [Abstract][Full Text] [Related]
20. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
